Dihydrotestosterone synthesis bypasses testosterone to drive castration-resistant prostate cancer

In the majority of cases, advanced prostate cancer responds initially to androgen deprivation therapy by depletion of gonadal testosterone. The response is usually transient, and metastatic tumors almost invariably eventually progress as castration-resistant prostate cancer (CRPC). The development o...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Chang, Kai-Hsiung, Li, Rui, Papari-Zareei, Mahboubeh, Watumull, Lori, Zhao, Yan Daniel, Auchus, Richard J., Sharifi, Nima
Format: Artigo
Jezik:Inglês
Izdano: National Academy of Sciences 2011
Teme:
Biological Sciences
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3158152/
https://ncbi.nlm.nih.gov/pubmed/21795608
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1073/pnas.1107898108
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki